Ruseska I., Zimmer A.
Cellular uptake and trafficking of peptide-based drug delivery systems for miRNA
European Journal of Pharmaceutics and Biopharmaceutics 191 (2023) 189-204
doi: 10.1016/j.ejpb.2023.08.019
2023
137. Ruseska I., Zimmer A.
Cellular uptake and trafficking of peptide-based drug delivery systems for miRNA
European Journal of Pharmaceutics and Biopharmaceutics 191 (2023) 189-204
doi: 10.1016/j.ejpb.2023.08.019
136. Crcarevska M.S., Dodov M.G., Geskovski N., Makreski P., Mihailova L., Petrushevska M., Shalabalija D., Zimmer A.
Comparative Studies of the Uptake and Internalization Pathways of Different Lipid Nano-Systems Intended for Brain Delivery.
Parmaceutics 15,8 (2023) 2082
doi: 10.3390/pharmaceutics15082082
135. Almer G., Fröhlich E., Fuchs J., Höller O., Kornmueller K., Prassl R., Schachner-Nedherer A., Schratter G., Vidakovic I., Wabitsch M., Zimmer A.
Lipid Nanoparticles as a Shuttle for Anti-Adipogenic miRNAs to Human Adipocytes.
Pharmaceutics 15,7 (2023) 1983
doi: 10.3390/pharmaceutics15071983
134. Corzo C., Crvenjak D., Fröhlich E., Lochmann D., Meindl C., Öhlinger K., Reyer S., Salar-Behzadi S., Sotirov K., Urich J., Zimmer A.
Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung.
International Journal of Pharmaceutics 642 (2023) 123201
doi: 10.1016/j.ijpharm.2023.123201
133. Clases D., Crafts P., de Vega R.G., Feldmann J., Lindsay Th., Paton L., Siboni H., Zimmer A.
The impact of corrosion on the adsorption of gaseous Hg0 onto the surface of steels: Implications for decommissioning in the oil and gas industry.
Journal of Hazardous Materials 458 (2023) 131975
doi: 10.1016/j.jhazmat.2023.131975
134. Corzo C., Crvenjak D., Fröhlich E., Lochmann D., Meindl C., Öhlinger K., Reyer S., Salar-Behzadi S., Sotirov K., Urich J., Zimmer A.
Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung.
International Journal of Pharmaceutics 642 (2023) 123201
doi: 10.1016/j.ijpharm.2023.123201
135. Almer G., Fröhlich E., Fuchs J., Höller O., Kornmueller K., Prassl R., Schachner-Nedherer A., Schratter G., Vidakovic I., Wabitsch M., Zimmer A.
Lipid Nanoparticles as a Shuttle for Anti-Adipogenic miRNAs to Human Adipocytes.
Pharmaceutics 15,7 (2023) 1983
doi: 10.3390/pharmaceutics15071983
136. Crcarevska M.S., Dodov M.G., Geskovski N., Makreski P., Mihailova L., Petrushevska M., Shalabalija D., Zimmer A.
Comparative Studies of the Uptake and Internalization Pathways of Different Lipid Nano-Systems Intended for Brain Delivery.
Parmaceutics 15,8 (2023) 2082
doi: 10.3390/pharmaceutics15082082
2022
127. Corzo C., Engel D., Karre J., Leitner L., Salar-Behzadi S., Schertel S., Teichmann Y., Zimmer A.
Going green: Development of a sustainable lipid-based enteric coating formulation for low-dose aspirin multiparticulate systems.
International Journal of Pharmaceutics 614 (2022) 121453
doi: 10.1016/j.ijpharm.2022.121453
128. Aleksić I., Ibrić S., Mirković M., Parojčić J., Piller M., Turković E., Vasiljević I., Zimmer A.
Processability evaluation of multiparticulate units prepared by selective laser sintering using the SeDeM Expert System approach.
International Journal of Pharmaceutics 629 (2022) 122337
doi: 10.1016/j.ijpharm.2022.122337
129. Afonyushkin T., Birukova A.A., Birukov K.G., Bochkov V., Gesslbauer B., Hellauer K., Ke Y., Mauerhofer C., Oskolkova O.V., Schmerda J., Zimmer A.
Low Concentrations of Oxidized Phospholipids Increase Stress Tolerance of Endothelial Cells.
Antioxidants 11, 9 (2022) 1741
doi: 10.3390/antiox11091741
130. Falsone F., Fresacher-Scheiber K., Grill L., Reiser M., Ruseska I., Siboni H., Zimmer A.
Modified Stability of microRNA-Loaded Nanoparticles.
Pharmaceutics 14, 9 (2022) 1829
doi: 10.3390/pharmaceutics14091829
131. Bäumers M., Breitkreutz J., Fligge M., Letofsky-Papst I., Zimmer A.
Personalized dermal patches - Inkjet printing of prednisolone nanosuspensions for individualized treatment of skin diseases.
International Journal of Pharmaceutics 122382 (2022)
doi: 10.1016/j.ijpharm.2022.122382
132. Kryeziu T.L., Haloci E., Loshaj-Shala A., Bagci U., Oral A., Stefkov G.J., Zimmer A.
Nanoencapsulation of "Origanum vulgare" essential oil into liposomes with anticancer potential.
Pharmazie 77, 6, 172-178 (2022)
doi: 10.1691/ph.2022.1230
2021
123. Salar-Behzadi S., Schertel S., Zimmer A.
Impact of Surface Properties of Core Material on the Stability of Hot Melt-Coated Multiparticulate Systems.
Pharmaceutics 13(3) (2021) 366
doi: 10.3390/pharmaceutics13030366
124. Karrer J., Laggner P., Salar-Behzadi S., Schertel S., Zimmer A.
Impact of polysorbate 65 ontripalmitin crystal growth and release stability of hot melt coated multiparticulate systems.
International Journal of Pharmaceutics 607 (2021) 120970
doi: 10.1016/j.ijpharm.2021.120970
125. Fresacher K., Petschacher Ch., Ruseska I., Zimmer A.
Use of Protamine in Nanopharmaceuticals - A Review.
Nanomaterials 11, 6 (2021)1508
doi: 10.3390/nano11061508
126. Aleksić I., Mirković M., Nenadović S., Parojčić J., Turković E., Vasiljević I., Zimmer A.
Investigation into liquisolid system processability based on the SeDeM Expert System approach.
International Journal of Pharmaceutics 605 (2021) 12847
doi: 10.1016/j.ijpharm.2021.120847
2020
117. Ruseska I., Schachner-Nedherer A.-L., Zimmer A.
Membrane interactions and cellular uptake of an amphipathic cell-penetrating peptide as a delivery system for miRNA.
Macedonian Pharmaceutical Bulletin 66 (1) (2020) 123-124
doi: 10.33320/maced.pharm.bull.2020.66.03.061
118. Fresacher K., Huemer B., Reiser M., Zimmer A.
An introduction of a new generation of Proticles.
Macedonian Pharmaceutical Bulletin 66, 1 (2020) 121-122
doi: 10.33320/maced.pharm.bull.2020.66.03.060
119. Huber A., Korbelius M., Kratky D., Radović B., Rainer S., Sachdev V., Vujić N., Zimmer A.
Intestine-specific DGAT1 deficiency improves atherosclerosis in apolipoprotein E knockout mice by reducing systemic cholesterol burden.
Atherosclerosis 310 (2020) 26-36
doi: 10.1016/j.atherosclerosis.2020.07.030
120. Parojčića J., Piller M., Turković E., Vasiljević I., Zimmer A.
An investigation into applicability of different compression behaviour assessment approaches for multiparticulate units characterization.
Powder Technology 379 (2020) 526-536
doi: 10.1016/j.powtec.2020.10.085
121. Chemelli A., Glatter O., Milak S., Zimmer A.
Vancomycin Loaded Glycerol Monooleate Liquid Crystalline Phases Modified with Surfactants.
Pharmaceutics 12, 6 (2020) 521
doi: 10.3390/pharmaceutics12060521
122. Leitner P., Nidetzky B., Petschacher B., Petschacher Ch., Zimmer A., Zong C.
Pharmaceutical use of nanocellulose produced by enzymes.
Macedonian Pharmaceutical Bulletin 66, Suppl 1. (2020) 125-126
doi: 10.33320/maced.pharm.bull.2020.66.03.062
2018 - 2019
111. Keser S., Timpe C., Zimmer A.
Development and evaluation of taste-masked pediatric minitablet formulations with bitter model drugs.
International Journal of Pharmaceutics 536 (2) (2018) 512
doi: 10.1016/j.ijpharm.2017.08.041
112. Schachner-Nedherer A.-L., Werzer O., Zimmer A.
A Protocol to Characterize Peptide-Based Drug Delivery Systems for miRNAs.
ACS Omega 4 (4) (2019) 7014-7022
doi: 10.1021/acsomega.8b03562
113. Chemelli A., Glatter, O., Milak S., Zimmer A.
Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
European Journal of Pharmaceutics and Biopharmaceutics 139 (2019) 279-299
doi: 10.1016/j.ejpb.2019.04.009
114. Corzo C., Laggner P., Salar-Behzadi S., Schaden L., Zimmer A.
Correlation between the solid state of lipid coating and release profile of API from hot melt coated microcapsules.
International Journal of Pharmaceutics 565 (2019) 569-578
doi: 10.1016/j.ijpharm.2019.05.036
115. Kornmueller K., Schachner-Nedherer A., Prassl R., Werzer O., Zimmer A.
Biological Activity Of miRNA-27a Using Peptide-based Drug Delivery Systems.
International Journal of Nanomedicine 14 (2019) 7795 - 7808
doi: 10.2147/IJN.S208446
116. Andreae F., Blass S., Decristoforo C., Fresacher K., Helbok A., Mair, Ch., Rangger Ch., Reiser M., von Guggenberg, E., Zimmer, A.
Comparison of PEGylated and non-PEGylated proticles: An in vitro and in vivo study.
European Journal of Pharmaceutical Sciences 139 (2019) 105063
doi: 10.1016/j.ejps.2019.105063
2017
104. Becker K., Hate S., Hohl R., Sacher S., Salar-Behzadi S., Schiemenz W., Stocker E., Zimmer A.
Application of ICH Q9 quality risk management tools for advanced development of hot melt coated multiparticulate systems.
Journal of Pharmaceutical Sciences 106 (2017) 278-290
doi: 10.1016/j.xphs.2016.09.025
105. Becker K., Gomes Lopes D., Haack D., Koutsamanis I., Laggner P., Salar-Behzadi S., Scheibelhofer O., Stehr M., Zimmer A.
Microphase separation in solid lipid dosage forms as the cause of drug release instability.
International Journal of Pharmaceutics 517, 1-2 (2017) 403-412
doi: 10.1016/j.ijpharm.2016.12.040
106. Diwoky C., Duta-Mare M., Eichmann T.O., Goeritzer M., Kolb D., Korbelius M., Kratky D., Lass A., Leopold C., Rainer S., Radovic B., Schlager S., Vujic N., Zimmer A., Zimmermann R.
Monoglyceride lipase deficiency affects hepatic cholesterol metabolism and lipid-dependent gut transit in ApoE−/− mice.
Oncotarget 16, 8 (20) (2017) 33122-33136
doi: 10.18632/oncotarget.16529
107. Bodak B., Christian P., Riegler H., Schrode B., Werzer O., Zimmer A.
Solvent Vapor Annealing of Amorphous Carbamazepine Films for Fast Polymorph Screening and Dissolution Alteration.
ACS Omega 2 (9) (2017) 5582–5590
doi: 10.1021/acsomega.7b00783
108. Gomes Lopes D., Salar-Behzadi S., Zimmer A.
Designing optimal formulations for hot-melt coating.
International Journal of Pharmaceutics 533 (2) (2017) 357-363
doi: 10.1016/j.ijpharm.2017.08.086
109. Faulhammer E., Paudel A., Stranzinger S., Wutscher T., Zellnitz S., Zimmer A.
Performance indicators for carrier-based DPIs: Carrier surface properties for capsule filling and API properties for in vitro aerosolisation.
International Journal of Pharmaceutics 536 (1) (2017) 326-335
doi: 10.1016/j.ijpharm.2017.12.004
110. Haack D., Hohl R., Kerschhaggl P., Koch K., Lochmann D., Sacher S., Salar-Behzadi S., Scheibelhofer O., Stocker E., Zimmer A.
Monitoring of a Hot Melt Coating Process via a Novel Multipoint Near-Infrared Spectrometer.
AAPS PharmSciTech 18 (2017) 182-193
doi: 10.1208/s12249-016-0504-4
2016
94. Hohl R., Scheibelhofer O., Stocker E., Behzadi S.S., Haack, D. Koch K., Kerschhaggl P., Lochmann D., Sacher S., Zimmer A.
Monitoring of a Hot Melt Coating Process via a Novel Multipoint Near-Infrared Spectrometer.
AAPS PharmSciTech 1-12 (2016) 182-193
doi: 10.1208/s12249-016-0504-4
95. Hörmann K., Zimmer A.
Drug delivery and drug targeting with parenteral lipid nanoemulsions — A review.
Journal of Controlled Release 223 (2016) 85-98
doi: 10.1016/j.jconrel.2015.12.016
96. Becker K., Saurugger E-M., Kienberger D., Lopes D., Haack D., Köberle M., Stehr M., Lochmann D., Zimmer A., Salar-Behzadi S.
Advanced stable lipid-based formulations for a patient-centric product design.
International Journal of Pharmaceutics 497,1-2 (2016) 136-149
doi: 10.1016/j.ijpharm.2015.11.039
97. Schimpel C., Rinner B., Absenger-Novak M., Meindl C., Fröhlich E., Falk A., Zimmer A., Roblegg E.
A novel in Vitro Model for Studying Nanoparticle Interactions with the Small Intestine.
EURO-NanoTox-Letters 6,1 (2016) 1-14
doi: 10.1515/entl-2015-0001
98. Gomes Lopes D., Garsuch V., Becker K., Paudel A., Stehr M. , ; Zimmer A., Salar-Behzadi S.
Improving the granule strength of roller-compacted ibuprofen sodium for hot-melt coating processing.
International Journal of Pharmaceutics 510, 1 (2016) 285-295, Manuscript Number: IJP-D-16-00424R
doi: 10.1016/j.ijpharm.2016.06.049
99. Sachdev V., Leopold C., Bauer R., Patankar J., Iqbal J., Obrowsky S., Boverhof R., Doktorova M., Scheicher B., Goeritzer M., Kolb D., Turnbull A., Zimmer A., Hoefler G., Hussain M.M., Groen A., Kratky D.
Novel role of a triglyceride-synthesizing enzyme: DGAT1 at the crossroad between triglyceride and cholesterol metabolism.
Biochimica and Biophysica Acta. Molecular and Cell Biology of Lipids 1861 (2016) 1132–1141
doi: 10.1016/j.bbalip.2016.06.014
100. Christian P., Röthel C., Tazreiter M., Zimmer A., Salzmann I., Resel R., Werzer O.
Crystallization of Carbamazepine in Proximity to Its Precursor Iminostilbene and a Silica Surface.
Crystal Growth & Design 16(5) (2016) 2771-2778
doi: 10.1021/acs.cgd.6b00090
101. Scheicher B., Lorenzer C., Gegenbauer K., Partlic J., Andreae F., Kirsch A., Rosenkranz A., Werzer O., Zimmer A.
Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration.
PLoS One 11,11 (2016) e0164149
doi: 10.1371/journal.pone.0164149
102. Christian P., Röthel C., Tazreiter M., Zimmer A., Salzmann I., Resel R., Werzer O.
Crystallization of Carbamazepine in Proximity to Its Precursor Iminostilbene and a Silica Surface.
Crystal Growth & Design 16(5) (2016) 2771-2778
doi: 10.1021/acs.cgd.6b00090
103. Pardeike J., Weber S., Zarfl HP., Zimmer A.
Itraconazole-loaded Nanostructured lipid carriers (NLC) for pulmonary treatment of aspergillosis in falcons.
European Journal of Pharmaceutics and Biopharmaceutics 108 (2016) 269-276
doi: 10.1016/j.ejpb.2016.07.018
2015
83. Teubl B., Schimpel C., Leitinger G., Bauer B., Fröhlich E., Zimmer A., Roblegg E.
Interactions between nano-TiO2 and the oral cavity: Impact of nanomaterial surface hydrophilicity/hydrophobicity.
Journal of Hazardous Materials 286 (2015), 298–305
doi: 10.1016/j.jhazmat.2014.12.064
84. Ehmann H., Baumgartner R., Reischl D., Roblegg E., Zimmer A., Resel R., Werzer O.
One Polymorph and Various Morphologies of Phenytoin at a Silica Surface Due to Preparation Kinetics.
Cryst. Growth Des (2015) 15 (1) 326–332
doi: 10.1021/cg501391j
85. Becker K., Salar-Behzadi S., Zimmer A.
Solvent-Free Melting Techniques for the Preparation of Lipid-Based Solid Oral Formulations.
Pharmaceutical Research 32(5) (2015) 1519-45
doi: 10.1007/s11095-015-1661-y
86. Bernhart E., Damm S., Wintersperger A., Nusshold C., Brunner AM., Plastira I., Rechberger G., Reicher H., Wadsack C., Zimmer A., Malle E., Sattler W.
Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells.
Biochem Pharmacol. 96(2) (2015) 119-130
doi: 10.1016/j.bcp.2015.05.007
87. Schimpel C., Werzer O., Fröhlich E., Leitinger G., Absenger-Novak M., Teubl B., Zimmer A., Roblegg E.
Atomic force microscopy as analytical tool to study physicomechanical properties of intestinal cells
Beilstein Journal of Nanotechnology 6 (2015) 1457–1466
doi: 10.3762/bjnano.6.151
88. Röthel C., Radziown M., Resel R., Zimmer A., Simbrunner C., Werzer, O.
Complex Behavior of Caffeine Crystallites on Muscovite Mica Surfaces
Crystal Growth & Design 15(9) (2015) 4563–4570
doi: 10.1021/acs.cgd.5b00833
89. Almer G., Mangge H., Zimmer A., Prassl R.
Lipoprotein-related and Apolipoprotein-mediated Delivery Systems for Drug Targeting and Imaging.
Current Medicinal Chemistry 0929-8673 22(31) (2015) 3631-3651
doi: 10.2174/0929867322666150716114625
90. Meindl C., Stranzinger S., Dzidic N., Salar-Behzadi S., Mohr S., Zimmer A., Fröhlich E.
Permeation of therapeutic drugs in different formulations across the airway epithelium in vitro.
PloS ONE 14 (2015) 1-19
doi: 10.1371/journal.pone.0135690
91. Sütő B, Weber S., Zimmer A., Farkas G., András Kelemen A., Budai-Szűcs M., Berkó S., Szabó-Révész P., Csányi E.
Optimization and design of an Ibuprofen-loaded nanostructured lipid carrier with a 23 full factorial design.
Chemical Engineering Research and Design 104 (2015) 488–496
doi: 10.1016/j.cherd.2015.09.010
92. Teubl BJ., Leitinger G., Schneider M., Lehr CM., Fröhlich E., Zimmer A., Roblegg E.
The buccal mucosa as a route for TiO2 nanoparticle uptake.
Nanotoxicology 9,2 (2015) 253-261
doi: 10.3109/17435390.2014.921343
93. Gomes Lopes D., Becker K., StehrM., Lochmann D., Haack D., Zimmer A., Salar-Behzadi S.
Role of Lipid Blooming and Crystallite Size in the Performance of Highly Soluble Drug-Loaded Microcapsules.
Journal of Pharmaceutical Sciences 104 (12) (2015) 4257-4265
doi: 10.1002/jps.24660
2014
73. Pardeike J., Zimmer A., Weber S.
Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art.
Eur. J. Pharm. Biopharm 86(1) (2014) 7-22
doi: 10.1016/j.ejpb.2013.08.013
74. Ehmann H., Roblegg E., Werzer O., Zimmer A.
Morphologies in Solvent-Annealed Clotrimazole Thin Films Explained by Hansen-Solubility Parameters.
Crystal Growth & Design 14,3 (2014) 1386-1391
doi: 10.1021/cg401859p
75. Ehmann H., Glasser B.J., Kann B., Khinast J., Saurugger E., Schrank S., Roblegg E., Werzer O., Windbergs M., Zimmer A.
Impact of Drying on Solid State Modifications and Drug Distribution in Ibuprofen-Loaded Calcium Stearate Pellets.
Mol. Pharmaceutics 11 (2) (2014) 599–609
doi: 0.1021/mp4005782
76. Absenger M., Fröhlich E., Leitinger G., Meindl C., Schimpel C., Teubl B., Roblegg E., Zimmer, A.
Development of an Advanced Intestinal In vitro Triple Culture Permeability Model to Study Transport of Nanoparticles.
Molecular Pharmaceutics 11 (3) (2014) 808–818
doi: 10.1021/mp400507g
77. Ehmann H., Grießer T., Keimel R., Schrank S., Werzer O., Winter S., Zimmer A.
Dissolution Testing of Hardly Soluble Materials by Surface Sensitive Techniques: Clotrimazole from an Insoluble Matrix.
Pharmaceutical Research 31 (2014) 2708–2715
doi: 10.1007/s11095-014-1368-5
78. Fröhlich E., Leitinger G., Lehr C.-M., Roblegg E., Schneider M., Teubl B., Zimmer A.
Uptake of Nano-Titanium-Dioxide in the Oral Cavity.
Nanotoxicology 29 (2014) 1-9
79. Baumgartner R., Ehmann H. M. A., Kunert B., Roblegg E., Werzer O., Zimmer A.
Morphologies of Phenytoin Crystals at Silica Model Surfaces: Vapor Annealing versus Drop Casting.
The Journal of Physical Chemistry C 118(24) (2014) 12855-1286
doi: 10.1021/jp502330e
80. Atkin R., Smith J.A.; Warr G., Webber G., Werzer O., Zimmer A.
Shear dependent viscosity of poly(ethylene oxide) in two protic ionic liquids.
Journal of Colloid and Interface Science 430 (2014) 56-60
doi: 10.1016/j.jcis.2014.05.006
81. Almer G., Gries A., Kellner J., Leitinger G., Mangge H., Prassl R., Scheicher B., Stelzer I., Summers K.L., Zimmer A.,
Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.
Int J Nanomedicine 9(1) (2014) 4211-4222
doi: 10.2147/IJN.S66830
82. Ehmann H.M., Kellner T., Kunert B., Roblegg E., Schrank S., Werzer O., Zimmer A.
Crystallographic Textures and Morphologies of Solution Cast Ibuprofen Composite Films at Solid Surfaces.
Molecular Pharmaceutics 11 (2014) 4084-4091
doi: 10.1021/mp500264e
2013
65. Barthelmes, J., Besenhard M., Bernkop-Schnürch A., Eitzlmayr A., Khinast J.G., Petschacher C., Wagner J., Zimmer A.
Thinking continuously: a microreactor for the production and scale-up of biodegradable, selfassembled nanoparticles.
Polymer Chemistry (2013) 4, 2342 - 2352
doi: 10.1039/C3PY20939C
66. Kunert B., Resel R., Roblegg E., Oehzelt M., Werzer O., Zimmer A.
Surface induced order of solution processed caffeine needles on silica and muscovite mica
Crystal Growth & Design (2013) 13 (3), 1322–1328
doi: 10.1021/cg301812m
67. Ablinger, E., Leitgeb, S., Zimmer, A.
Differential scanning fluorescence approach using a fluorescent molecular rotor to detect thermostability of proteins in surfactant-containing formulations
International Journal of Pharmaceutics (2013) 441 (1-2) 255-260
doi: 10.1016/j.ijpharm.2012.11.035
68. Eitzlmayr A., Fröhlich E., Teubl BJ., Meindl C., Roblegg E., Zimmer A.,
In-vitro permeability of neutral polystyrene particles via buccal mucosa
Small (2013) 9 (3) 457-466
doi: 10.1002/smll.201201789
69. Hohl R., Kann, B., Khinast, J., Roblegg, E., Schrank, S., Windbergs, M., Zimmer, A.
Microstructure of calcium stearate matrixpellets: A Function of the Drying Process
Journal of Pharmaceutical Sciences (2013) 102 (11) 3987-3997
doi: 10.1002/jps.23707
70. Diesner S.C., Hofmeister A., Jensen-Jarolim E., Lukschal A., Pali-Schöll I., Roth-Walter F., Scheicher B., Starkl P., Stremnitzer C., Szöllösi H., Zimmer A.
Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice
European Journal of Pharmaceutics and Biopharmaceutics (2013) 56-64
doi: 10.1016/j.ejpb.2013.03.003
71. Absenger M., Fröhlich E., Leitinger G., Teubl BJ., Roblegg E., Zimmer A.,
The oral cavity as a biological barrier system: Design of an advanced buccal in vitro permeability model
Eur J Pharm Biopharm. (2013) 386-393
doi: 10.1016/j.ejpb.2012.10.021
72. Bernhart E., Damm S., Devaney T., Ireson C., Raynham T., Sattler W., Wintersperger A., Zimmer A.
Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro
Experimental Cell Research (2013) 319(13), 2037-2048
doi: 10.1016/j.yexcr.2013.03.029
2012
58. Mosgoeller W., Prassl R., Zimmer A.
Nanoparticle-mediated treatment of pulmonary arterial hypertension
Methods in Enzymology 508 (2012) 325-354.
doi: 10.1016/B978-0-12-391860-4.00017-3
59. Ablinger E., Keller W., Prassl R., Wegscheider S., Zimmer A.
Effect of protamine on the solubility and deamidation of human growth hormone
International Journal of Pharmaceutics 427 (2012) 209– 216.
doi: 10.1016/j.ijpharm.2012.01.061
60. Ablinger E., Hellweger M., Leitgeb S., Zimmer A.
Evaluating the effects of buffer conditions and extremolytes on thermostability of granulocyte coloy-stimulating factor using high-throughput screening combined with design of experiments
International Journal of Pharmaceutics 436 (2012) 744-752
doi: 10.1016/j.ijpharm.2012.07.046
61. Matsko N., Pardeike J., Weber S., Zimmer A.
Formation of a physical stable delivery system by simply autoclaving nanostructured lipid carriers (NLC)
International Journal of Pharmaceutics (2012) 439 (1-2), 22-27
doi: 10.1016/j.ijpharm.2012.09.018
62. Glasser B.J., Hodzic A., Khinast J., Schrank S., Roblegg E., Zimmer A.
Ibuprofen-loaded calcium stearate pellets: Drying-induced variations in dosage form properties
AAPS PharmSciTech 13 (2)6 (2012) 686-698
doi: 10.1208/s12249-012-9791-6
63. Fröhlich E., Meindl C., Roblegg E., Teubl B., Zaversky M., Zimmer A.
Evaluation of a physiological in-vitro system to study the transport of nanomaterials through the buccal mucosa
Nanotoxicology 6 (2012) 399-413
doi: 10.3109/17435390.2011.580863
64. Buchmeiser M.R., Gatschelhofer C., Griesbacher M., Pieber T.R., Prasch A., Sinner F.M., Wernig K., Zimmer A.,
Monolithic Pre-Columns as Efficient Tools for Guiding the Design of Nanoparticulate Drug-Delivery Formulations
Analytical Chemistry (2012) 84 (17), 7415-7421
doi: 10.1021/ac3012208
2011
48. Bauer W., Brenn G., Eitzinger B., Gruber M.M., Khinast J.G., Schroedl N., Voura C., Zimmer A.
Printable Medicines - A Microdosing Device for the Production of Personalized Oral Dosage Forms.
Pharmaceutical Technology Europe 23 (1) (2011) 32-36
49. Beubler E., Dittrich P., Haltmeyer K., Roblegg E., Zimmer A.
Pharmacokinetics of a Novel Liquid Controlled Release Codeine Formulation.
Drug Development and Industrial Pharmacy 37(9) (2011) 1119-24
doi: 10.3109/03639045.2011.561351
50. Almer G., Frascione D., Gradauer K., Haj-Yahya S., Leitinger G., Mangge H., Pabst G., Prassl R., Rattenberger J., Saba-Lepek M.,
Wagner J., Wernig K., Zimmer A.,
Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques.
International Journal of Nanomedicine 6 (2011) 1279-1290
doi: 10.2147/IJN.S18739
51. Haber T., Pardeike J., Plank H., Wagner J., Weber S., Zarfl H.P., Zimmer A.
Development of an Itraconazole-loaded Nanostructured Lipid Carrier (NLC) formulation for pulmonary application.
International Journal of Pharmaceutics 419 (2011) 329– 338.
doi: 10.1016/j.ijpharm.2011.07.040
52. Griesbacher M., Khinast J., Radl S., Roblegg E., Schrank S., Zimmer A.,
Use of the Direct Compression Aid Ludiflash® for the Preparation of Pellets via Wet Extrusion/Spheronization.
Drug Development and Industrial Pharmacy 37(10) (2011) 1231-1243
doi: 10.3109/03639045.2011.566271
53. Eitzlmayr A., Khinast J.G., Petschacher Ch., Radl S., Suzzi D., Zimmer A.
Modeling and Simulation of Polyacrylic acid/Protamine Nanoparticle Precipitation.
Soft Matter 7 (2011) 9484-9497
doi: 10.1039/C1SM05501A
54. Hodzic A., Jäger E., Khinast J., Koscher G., Mohr S., Roblegg E., Zimmer A.
Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion.
European Journal of Pharmaceutics and Biopharmaceuticsr 79 (2011) 635–645
doi: 0.1016/j.ejpb.2011.07.004
55. Gruber M., Khinast J.G., Pardeike J., Schrödl N., Strohmeier D., Voura C., Zimmer A.
Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines.
International Journal of Pharmaceutics 420 (2011) 93-100
doi: 10.1016/j.ijpharm.2011.08.033
56. Paukert T., Sailer R., Strauss W. S. L., Schubert-Zsilavecz M., Zimmer A.
Glutathione peroxidase isoenzymes in human tumor cell lines.
Die Pharmazie 66 (2011) 894-898
doi: 10.1691/ph.2011.1540
57. Falk A., Fröhlich E., Roblegg E., Sinner F., Zimmer A.
European Centre for Nanotoxicology: A Proactive Risk-assessment Nanotechnology lnitiative
Academy of Science Malaysia Journal, 5 (1) (2011) 43-52
doi: 10.1111/joim.12109